Novel Therapeutic Strategies for Metastatic Prostate Cancer Care

IF 25.3 1区医学 Q1 UROLOGY & NEPHROLOGY

European urology Pub Date : 2025-07-19 DOI:10.1016/j.eururo.2025.06.013

Alessia Cimadamore, Cristina Boixareu, Adam Sharp, Himisha Beltran, Johann S. de Bono

引用次数: 0

Abstract

The elucidation of prostate cancer biology and genomics has led to new therapies improving disease outcomes with novel androgen receptor (AR) pathway inhibitors (ARPIs), taxanes, and targeted therapeutics that require disease molecular stratification.

查看原文本刊更多论文

转移性前列腺癌护理的新治疗策略

前列腺癌生物学和基因组学的阐明带来了新的治疗方法，通过新的雄激素受体（AR）途径抑制剂（arpi）、紫杉烷和需要疾病分子分层的靶向治疗来改善疾病的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology 医学-泌尿学与肾脏学

CiteScore

43.00

自引率

2.60%

发文量

1753

审稿时长

23 days

期刊介绍： European Urology is a peer-reviewed journal that publishes original articles and reviews on a broad spectrum of urological issues. Covering topics such as oncology, impotence, infertility, pediatrics, lithiasis and endourology, the journal also highlights recent advances in techniques, instrumentation, surgery, and pediatric urology. This comprehensive approach provides readers with an in-depth guide to international developments in urology.